Further analysis demonstrated that the anti-T2DM mechanisms of AGE were mainly related to suppressing inflammation, oxidative stress, endothelial dysfunction, dyslipidemia, insulin resistance, T2DM-related complications and enhancing immune response, and insulin secretion. This evidence concerns the gene INS and endothelial dysfunction.